Placental lactogen-I variant utilizes the prolactin receptor signaling pathway. 1996

C B Cohick, and G Dai, and L Xu, and S Deb, and T Kamei, and G Levan, and C Szpirer, and J Szpirer, and S C Kwok, and M J Soares
Department of Physiology, University of Kansas Medical Center, Kansas City 66160-7401, USA.

Placenta lactogen-I variant (PL-Iv) is a member of a family of proteins expressed by the rat placenta with characteristics similar to prolactin (PRL). In this report, we present the molecular cloning, chromosomal localization, and heterologous expression of PL-Iv. Nucleotide sequence analysis of the PL-Iv cDNA clone predicted a precursor protein of 223 amino acids, including a 28-amino acid signal sequence. The PL-Iv gene was localized to chromosome 17 of the rat genome, which also carries other members of the PRL gene family. PL-Iv heterologously expressed in Chinese Hamster ovary (CHO) cells exhibited similar immunoreactive and electrophoretic characteristics with PL-Iv produced by the rat placenta. N-terminal sequencing verified the identity and purity of the recombinant PL-Iv species and the site of cleavage of the signal peptide from the mature secreted PL-Iv species. Recombinant PL-Iv was shown to bind to ovarian and liver PRL receptors, stimulate the proliferation of Nb2 lymphoma cells, and activate Jak2. Each of these actions is consistent with PL-Iv utilizing the PRL receptor signal transduction pathway.

UI MeSH Term Description Entries
D010928 Placental Lactogen A polypeptide hormone of approximately 25 kDa that is produced by the SYNCYTIOTROPHOBLASTS of the PLACENTA, also known as chorionic somatomammotropin. It has both GROWTH HORMONE and PROLACTIN activities on growth, lactation, and luteal steroid production. In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. Placental lactogen is also an insulin antagonist. Choriomammotropin,Chorionic Somatomammotropin, Human,Human Placental Lactogen,Lactogen Hormone, Placental,Mammotropic Hormone, Placental,Somatomammotropin, Chorionic,Choriomammotrophin,HCS (Human Chorionic Somatomammotropin),HPL (Human Placental Lactogen),PAPP-D,Placental Luteotropin,Pregnancy-Associated Plasma Protein D,Chorionic Somatomammotropin,Human Chorionic Somatomammotropin,Lactogen, Placental,Luteotropin, Placental,Placental Lactogen, Human,Placental Mammotropic Hormone,Pregnancy Associated Plasma Protein D
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011981 Receptors, Prolactin Labile proteins on or in prolactin-sensitive cells that bind prolactin initiating the cells' physiological response to that hormone. Mammary casein synthesis is one of the responses. The receptors are also found in placenta, liver, testes, kidneys, ovaries, and other organs and bind and respond to certain other hormones and their analogs and antagonists. This receptor is related to the growth hormone receptor. Prolactin Receptors,PRL Receptors,Prolactin Receptor,Receptors, PRL,Receptor, Prolactin
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D005260 Female Females
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

C B Cohick, and G Dai, and L Xu, and S Deb, and T Kamei, and G Levan, and C Szpirer, and J Szpirer, and S C Kwok, and M J Soares
January 1991, The Journal of biological chemistry,
C B Cohick, and G Dai, and L Xu, and S Deb, and T Kamei, and G Levan, and C Szpirer, and J Szpirer, and S C Kwok, and M J Soares
June 1996, Endocrine,
C B Cohick, and G Dai, and L Xu, and S Deb, and T Kamei, and G Levan, and C Szpirer, and J Szpirer, and S C Kwok, and M J Soares
July 1991, Molecular and cellular endocrinology,
C B Cohick, and G Dai, and L Xu, and S Deb, and T Kamei, and G Levan, and C Szpirer, and J Szpirer, and S C Kwok, and M J Soares
September 2000, Nature structural biology,
C B Cohick, and G Dai, and L Xu, and S Deb, and T Kamei, and G Levan, and C Szpirer, and J Szpirer, and S C Kwok, and M J Soares
September 1971, Clinical obstetrics and gynecology,
C B Cohick, and G Dai, and L Xu, and S Deb, and T Kamei, and G Levan, and C Szpirer, and J Szpirer, and S C Kwok, and M J Soares
November 1989, Molecular endocrinology (Baltimore, Md.),
C B Cohick, and G Dai, and L Xu, and S Deb, and T Kamei, and G Levan, and C Szpirer, and J Szpirer, and S C Kwok, and M J Soares
October 1974, Biochemical and biophysical research communications,
C B Cohick, and G Dai, and L Xu, and S Deb, and T Kamei, and G Levan, and C Szpirer, and J Szpirer, and S C Kwok, and M J Soares
April 1997, The Journal of endocrinology,
C B Cohick, and G Dai, and L Xu, and S Deb, and T Kamei, and G Levan, and C Szpirer, and J Szpirer, and S C Kwok, and M J Soares
March 1989, The Journal of clinical investigation,
C B Cohick, and G Dai, and L Xu, and S Deb, and T Kamei, and G Levan, and C Szpirer, and J Szpirer, and S C Kwok, and M J Soares
January 1990, Progress in clinical and biological research,
Copied contents to your clipboard!